Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

European Pharmaceutical Pricing & Reimbursement

5th October to 6th October 2015, London, United Kingdom

Overview

Open/Close

Pricing and Reimbursement is one of the most plastic fields in finance with European countries all having different policies on pricing and reimbursement with pros and cons to each system.

Biosimilars have become a hot topic in the field. Obtainingmarketing authorisation for biosimilars requires a extensive and costly process of clinical development and does not automatically ensure substitutability with the reference product. Therefore, the market dynamic of biological medicines is likely to diverge from that of small  -molecule medicines. This results in far smaller market penetration is significantly and smaller savings in expenditure when compared with small molecule
generics.

SMi will be hosting its prestigious Pharmaceutical Pricing and Reimbursement conference. It will be held on the 5th to the 6th October 2015 at the Marriott Hotel Regents Park, London. The conference is one of the most established in the world having run for 21 years highlighting the changes in the field over this period of time.
 

 

Our experts will provide advice on current changes and highlight methods to deal with changes through case study examples and discussion. This year’s agenda will have a strong focus on international changes in policy along with an in-depth section on biosimilar dugs and the impact they have had on Pricing and Reimbursement through different nations in Europe.

Key topics include:

  • The impact of Biosimilars: a European Perspective
  • Cost to benefit analysis: developing new reimbursement schemes
  • Purchasing Mechanisms and Working with Payers
  • Case studies in reforms

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close